<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Riyana Noor Oktaviyanti</style></author><author><style face="normal" font="default" size="100%">Cita Rosita Sigit Prakoeswa</style></author><author><style face="normal" font="default" size="100%">Esti Hendradi,</style></author><author><style face="normal" font="default" size="100%">Anang Endaryanto</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">In-silico Prediction of Epigallocatechin-3-Gallate (EGCG) vs Retinol in Photoaging Therapy</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Docking</style></keyword><keyword><style  face="normal" font="default" size="100%">EGCG</style></keyword><keyword><style  face="normal" font="default" size="100%">HAS</style></keyword><keyword><style  face="normal" font="default" size="100%">MMP1</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">366-371</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Skin aging is a cumulative damage that occurs due to complex biological processes from genetic and environmental factors that are evident in individual's appearance. Clinically photoaging causes wrinkling, telangiectasia, dryness, pigment changes and loss of elasticity. As the predominant element found in green tea, epigallocatechin-3-gallate (EGCG) exhibits an active physiological function observed in both human and animal skin. Exposure to the two components of solar UV radiation that reach the earth surface, UVA (320–400nm) and UVB (290–320nm), leads to protein oxidative damage, lipid oxidation, DNA chain damage, and depletion of antioxidant enzymes. Since 1984, all-trans retinol has been incorporated into over-the-counter (OTC) cosmetic products, yet its potential in treating photoaging continues to be investigated. &lt;strong&gt;Methods: &lt;/strong&gt;Search Profile EGCG, Retinol, Hyaluronan, and then Bioactive Prediction with SAR. Predicted EGCG targets were analyzed using Comparative Toxicogenomics Database. Compound Profile Similarity with Tanimoto Similarity. Using AlphaFold model, we obtained three-dimensional configuration of Hyaluronan Synthase 1, as designated target protein in this study, from Uniprot database (https://www. uniprot.org/) with identifier Q92839.&lt;strong&gt; Results:&lt;/strong&gt; Based on SAR analysis to predict potential bioactivity, it shows that EGCG has better potential than retinol as an antioxidant and free radical scavenger. Target prediction with CTD shows that in curated studies the EGCG CTD is able to target COL1A1, HAS1, NFE2L2, and MMP1. Based on tanimono similarity, the similarity between EGCG and Hyaluron is higher than Hyaluron and Retinol. &lt;strong&gt;Conclusions:&lt;/strong&gt; Docking analysis shows that it is predicted that EGCG is better at interacting with HAS1 and MMP1.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">366</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Riyana Noor Oktaviyanti&lt;sup&gt;1&lt;/sup&gt;, Cita Rosita Sigit Prakoeswa &lt;sup&gt;2*&lt;/sup&gt;, Esti Hendradi&lt;sup&gt;3&lt;/sup&gt;, Anang Endaryanto&lt;sup&gt;4&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Doctoral Program of Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga - Dr Soetomo General Academic Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Airlangga, Kampus C Mulyorejo, Surabaya, Indonesia&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Pediatrics, Faculty of Medicine, Universitas Airlangga - Dr Soetomo General Academic Hospital, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Puja Adi Priatna</style></author><author><style face="normal" font="default" size="100%">Rizki Rahmadi Pratama</style></author><author><style face="normal" font="default" size="100%">Retno Widyowati</style></author><author><style face="normal" font="default" size="100%">Sukardiman</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Molecular Docking Estrogen Receptor Alpha Antagonist and P53- MDM2 Inhibitor, ADMET Prediction of Alkaloid Compound from Mitragyna speciosa for Breast Cancer Therapy</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">ADMET</style></keyword><keyword><style  face="normal" font="default" size="100%">Alkaloid</style></keyword><keyword><style  face="normal" font="default" size="100%">Breast cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Docking</style></keyword><keyword><style  face="normal" font="default" size="100%">Mitragyna speciosa</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">912-916</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Breast cancer is one of the major universal health problems affecting more than two million cases per year. Estrogen receptor alpha (ERα) and P53 are common targets for the treatment of breast cancer and are primarily involved in cell proliferation. The function of p53 protein is regulated by direct binding to MDM2 protein. Therefore, inhibition of p53-MDM2 interaction leads to reactivating p53 activity. Alkaloid compounds generally have potential anticancer effect. Alkaloid compound from &lt;em&gt;Mitragyna speciosa &lt;/em&gt;have the potential for anticancer. &lt;strong&gt;Methods:&lt;/strong&gt; The method used is molecular docking with AutoDockTools 1.5.6 program. Predict the properties of physicochemical, pharmacokinetic, and toxicity prediction tests (ADMET) using pkCSM.&lt;strong&gt; Results:&lt;/strong&gt; The results showed that speciophylline, corynoxine A, and corynoxine B have the best values in free binding energy (ΔG) for estrogen receptor (ERα) alpha receptor. Meanwhile, mitraphylline, mitrafoline, and corynoxine B have the best values for protein P53. Predict ADMET using the pkCSM, the alkaloid compound has strong lipophilicity and good permeability so it predicts the ability to penetrate intestinal cell membranes and the skin membrane. Spesiofilin, mitraphylline, and mitrafolin are not expected hepatotoxic. &lt;strong&gt;Conclusion:&lt;/strong&gt; Speciophylline and mitraphylline have potential as anticancer drugs through the inhibitory of estrogen receptor alpha and MDM2 reseptor.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article </style></work-type><section><style face="normal" font="default" size="100%">912</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Puja Adi Priatna, Rizki Rahmadi Pratama, Retno Widyowati, Sukardiman*&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Department of Pharmaceutical Sciences, Faculty of Pharmacy, Airlangga University, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Khoirul Rista Abidin</style></author><author><style face="normal" font="default" size="100%">Ronny Lesmana</style></author><author><style face="normal" font="default" size="100%">Mas Rizky Anggun Adipurna Syamsunarno</style></author><author><style face="normal" font="default" size="100%">Kelana Kusuma Dharma</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Potential Role of Mitragynine as Lipolysis Stimulator via Adrenergic Signalling: Docking Model Study</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adrenergic</style></keyword><keyword><style  face="normal" font="default" size="100%">Docking</style></keyword><keyword><style  face="normal" font="default" size="100%">Lipolysis</style></keyword><keyword><style  face="normal" font="default" size="100%">Mitragynine</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">October 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">527-531</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Backgrounds:&lt;/strong&gt; Mitragynine is the most popular of the more than 50 alkaloids contained in &lt;em&gt;M.Speciosa.&lt;/em&gt; In particular, the Mitragynine alkaloid has the potential to increase lipid (fats) metabolism through specific pathways such as adenylyl cyclase signaling&lt;em&gt; via &lt;/em&gt;adrenergic receptors. In this case, Asp Amino acid and Ser are the types of residues that can activate adenylyl cyclase to initiate a series of activities in cells.&lt;strong&gt; Methods: &lt;/strong&gt;This study used Mitragynine ligand and adrenergic receptors (α1b, α2a, α2b, α2c dan β1). The receptor candidates were tested using Autodock whose test results were presented in the form of tables and 3-dimensional images using the Biovia Discovery Studio. &lt;strong&gt;Results: &lt;/strong&gt;Hydrogen bonds were formed between Mitragynine and the amino acids Asp and Ser at the β1-adrenergic receptor. The binding amino acids were found in Ser20 and Asp21 with energy bond of -5.26 kcal/mol and IC50: 111.35 ppm. Meanwhile, at the adrenergic receptor α2b there was only Asp residue that formed hydrogen bond with Mitragynine namely Asp218A. The energy bond formed between the two was -5.19 kcal/mol and IC50: 125.04 ppm. &lt;strong&gt;Conclusion&lt;/strong&gt;: Mitragynine has the potential to stimulate lipolysis through the pathways of α2b and β1-adrenergic receptors.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">527</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Khoirul Rista Abidin&lt;sup&gt;1,2&lt;/sup&gt;, Ronny Lesmana&lt;sup&gt;3,4*&lt;/sup&gt;, Mas Rizky Anggun Adipurna Syamsunarno&lt;sup&gt;4&lt;/sup&gt;, Kelana Kusuma Dharma&lt;sup&gt;5&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Biotechnology Study Program, Universitas Padjadjaran, Sumedang-45363, Jawa Barat, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Medical Laboratory Technology, Politeknik ‘Aisyiyah Pontianak Pontianak-78114, Kalimantan Barat, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Central Laboratory of Molecular Physiology, Universitas Padjadjaran Sumedang-45363, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Basic Medical Science, Universitas Padjadjaran Sumedang-45363, Jawa Barat, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of Nursing, Politeknik Kesehatan Kementerian Kesehatan Pontianak-78124, Kalimantan Barat, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vivek Jagadeesan Sharavanan</style></author><author><style face="normal" font="default" size="100%">Muthusaravanan Sivaramakrishnan</style></author><author><style face="normal" font="default" size="100%">Ram Kothandan</style></author><author><style face="normal" font="default" size="100%">Shanmugaprakash Muthusamy</style></author><author><style face="normal" font="default" size="100%">Kumaravel Kandaswamy</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Molecular Docking Studies of Phytochemicals from Leucas aspera Targeting Escherichia coli and Bacillus subtilis Subcellular Proteins</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antimicrobials</style></keyword><keyword><style  face="normal" font="default" size="100%">Computational screening</style></keyword><keyword><style  face="normal" font="default" size="100%">Docking</style></keyword><keyword><style  face="normal" font="default" size="100%">Phytochemicals</style></keyword><keyword><style  face="normal" font="default" size="100%">Subcellular proteins</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">278-285</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;!-- x-tinymce/html --&gt;&lt;strong&gt;Objective:&lt;/strong&gt; Bacterial subcellular proteins play a vital role in cell division, pilus assembly and virulence. In addition, such proteins were perceived as potential antimicrobial targets. Therefore, in this article we attempt to screen for potential phytochemicals that can target those subcellular proteins. &lt;strong&gt;Methods:&lt;/strong&gt; A computational screening for phytochemicals from Leucas aspera with better bioavailability followed by molecular docking studies for better understanding of interaction between phytochemical and target proteins. &lt;strong&gt;Results:&lt;/strong&gt; erythro-2-(4-allyl-2,6- dimethoxyphenoxy)-1-(4-hydroxy-3-methoxyphenyl) propan-1-ol and Leucasperone B from Leucas aspera possess great binding affinity (&amp;gt; -100 kcal/mol) towards one or more bacterial subcellular protein targets and possess bioavailability. &lt;strong&gt;Conclusion:&lt;/strong&gt; Based on the docking result we claim that erythro-2-(4-allyl-2,6-dimethoxyphenoxy)-1-(4-hydroxy-3-methoxyphenyl) propan-1-ol and Leucasperone B could serve as an effective antimicrobial compounds to treat bacterial infections.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">278</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;!-- x-tinymce/html --&gt;&lt;!-- x-tinymce/html --&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Vivek Jagadeesan Sharavanan, Muthusaravanan Sivaramakrishnan, Ram Kothandan, Shanmugaprakash Muthusamy, Kumaravel Kandaswamy*&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&amp;nbsp;Department of Biotechnology, Laboratory of Molecular Biology and Genetic Engineering, Kumaraguru College of Technology, Coimbatore, Tamil Nadu, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jancy Varghese</style></author><author><style face="normal" font="default" size="100%">S. Rajamani</style></author><author><style face="normal" font="default" size="100%">Betty Daniel</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antimicrobial Potential of Crude Extracts of Thespesia populnea L. Flower on Multiple Drug Resistant Opportunistic Pathogens in HIV/AIDS</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antibiogram</style></keyword><keyword><style  face="normal" font="default" size="100%">Antimicrobial</style></keyword><keyword><style  face="normal" font="default" size="100%">Biofilm</style></keyword><keyword><style  face="normal" font="default" size="100%">Docking</style></keyword><keyword><style  face="normal" font="default" size="100%">Inhibition</style></keyword><keyword><style  face="normal" font="default" size="100%">Multidrug Resistant</style></keyword><keyword><style  face="normal" font="default" size="100%">Opportunistic Pathogens</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2018</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/530</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">590-597</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; &lt;em&gt;Thespesia populnea&lt;/em&gt; L. commonly known as tulip tree or &amp;lsquo;portia&amp;rsquo; tree has been traditionally used for different illnesses. &lt;em&gt;Thespesia populnea&lt;/em&gt; L. is considered to have high tannin content and have high therapeutic value. &lt;strong&gt;Purpose:&lt;/strong&gt; The antifungal and antibacterial potential of &lt;em&gt;T. populnea&lt;/em&gt; L. should be checked on multiple drug resistant opportunistic pathogens &lt;em&gt;Pseudomonas aeruginosa&lt;/em&gt; and &lt;em&gt;Candida albicans&lt;/em&gt; in HIV/AIDS patients. &lt;strong&gt;Methods:&lt;/strong&gt; In order to check the effect of antibiotics antibiogram was studied with antibiotic sensitivity discs. To study the major factor affecting resistance test on formation of biofilm was done by tube and plate methods. The dried flower powder was subjected to sauxlaut hot extraction and the crude extract was analysed by Gas Chromatography and Mass Spectrophotoscopy. Antimicrobial potential of the ethyl acetate extract of the flower was checked by well agar diffusion, UV Spectrometry for growth rate and docking of selected compounds on the microbes of our study by the application of a software. &lt;strong&gt;Results:&lt;/strong&gt; The tested extracts and the selected compounds have showed significant results in the antimicrobial activities against the opportunistic pathogens in human. Higher the concentration of the extracts better is the inhibition of microbes. &lt;strong&gt;Conclusion:&lt;/strong&gt; The study provides a scientific rationale for the traditional use in the management of opportunistic pathogens which are multidrug resistant.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">590</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Jancy Varghese&lt;sup&gt;1&lt;/sup&gt;, S Rajamani&lt;sup&gt;2&lt;/sup&gt;, Betty Daniel&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Research Scholar, Bharathiar University Coimbatore, Tamil Nadu, INDIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Associate professor, PG and Research Centre, St.Joseph&amp;rsquo;s College Bangalore University, Karnataka INDIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Head of the Department and Associate professor, PG and Research Centre, Karnataka St.Joseph&amp;rsquo;s College Bangalore University, INDIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Niken Indriyanti</style></author><author><style face="normal" font="default" size="100%">Afrillia Nuryanti Garmana</style></author><author><style face="normal" font="default" size="100%">Finna Setiawan</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Repairing Effects of Aqueous Extract of Kalanchoe pinnata (Lmk) Pers. on Lupus Nephritis Mice</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Docking</style></keyword><keyword><style  face="normal" font="default" size="100%">Glomerulonephritis</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Lupus</style></keyword><keyword><style  face="normal" font="default" size="100%">Proteinuria</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2018</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/522</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">548-552</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;em&gt;Kalanchoe pinnata&lt;/em&gt; (Lmk) Pers (KP) has an immunosuppressive effect on delayed-type hypersensitivity test. Based on it, this research aimed to determine the repairing effects of aqueous extract of KP on lupus nephritis mice and identified its active compound. The KP extract profile was determined using UPLC-QTOF-MS/MS instrument. We examined six mice groups consisting of three curative treatment groups, one standard group receiving prednisone, one preventive group receiving KP extract, and one healthy (healthy and untreated) group. At the end of the experiment, we measured the proteinuria and renal histology parameters. To recognize the active compound in the KP profile, we performed &lt;em&gt;in silico&lt;/em&gt; assays for the flavonoid compounds to bind to the glucocorticoid receptor. We played &lt;em&gt;in silico&lt;/em&gt; tests for the flavonoid compounds to identify the active compound in the KP profile. We found the repairing effect of KP was detected in the kidney, demonstrated by its low proteinuria level and its better tissue structure. In the curative group, the urine protein level and its glomerular inflammation decreased. In the preventive group, the aqueous extract of KP could prevent lupus nephritis manifestations in the kidney. Bryophyllin A is the most active compound of the KP. However, further research is needed to understand the mechanism involved. We conclude, the aqueous extract, especially its bryophyllin A, have beneficial effects in repairing the function and tissue structure of lupus manifestations in mice kidney.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">548</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Niken Indriyanti&lt;sup&gt;1*&lt;/sup&gt;, Afrillia Nuryanti Garmana&lt;sup&gt;2&lt;/sup&gt;, Finna Setiawan&lt;sup&gt;3&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology, Faculty of Pharmacy, Mulawarman University, East Kalimantan, INDONESIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, Bandung Institute of Technology, West Java, INDONESIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Surabaya, East Java, INDONESIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alexander Victory</style></author><author><style face="normal" font="default" size="100%">Rezi Riadhi Syahdi</style></author><author><style face="normal" font="default" size="100%">Arry Yanuar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Virtual Screening of Indonesian Herbal Database as Murine Double Minute-2 (MDM2) Inhibitor</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Docking</style></keyword><keyword><style  face="normal" font="default" size="100%">Indonesian Herbal</style></keyword><keyword><style  face="normal" font="default" size="100%">Inhibitor</style></keyword><keyword><style  face="normal" font="default" size="100%">MDM2</style></keyword><keyword><style  face="normal" font="default" size="100%">Virtual Screening</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">1184-1189</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Murine Double Minute-2 (MDM2) overexpression causes the p53 deficiency, so the role p53 as a cell regulator does not work in the case of cancer. &lt;strong&gt;Methods:&lt;/strong&gt; In this study, virtual screening of Indonesian herbal database to discover MDM2 inhibitors was carried out. Autodock and Autodock Vina validated with Directory of Useful Decoy-Enhanced (DUD-E). Validation parameters were performed with Enrichment Factor, Receiver Operating Characteristics, and Area Under Curve. &lt;strong&gt;Results:&lt;/strong&gt; The validation with the grid box 70x70x70 on Autodock resulting AUC value 0.72, while in Autodock Vina 0.43. Autodock Vina did not fulfilll the standard value but still used for comparison. Based on the virtual screening result, top ten compounds from Autodock are Nimolicinol, Jacoumaric acid, Isoarborinol, Lantic acid, Diosgenin, Theasaponin E1, Taraxasterol, Leucadenone C, Simiarenol, and Alpha-Amyrin were found to have strong interaction with MDM2, with binding energy (&amp;Delta;G) ranging from -8.83 to -9.65 kcal/mol. The Autodock Vina screening resulted in the identification of Yuehchukene, Morusin, Cyanidin, Leucadenone C, Roxburghine-B, Ocidentoside, Beta-sitosterol, Curine, Withangulatin, and Jacoumaric acid as potential inhibitors with binding energy (&amp;Delta;G) ranging from -8.7 to -9.4 kcal/mol. &lt;strong&gt;Conclusion:&lt;/strong&gt; Jacoumaric acid and Leucadenone C were shown to interact with the active site in MDM2 at residues Leu54, Ile61, Met62, and Ile99.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">1184</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Alexander Victory, Rezi Riadhi Syahdi, Arry Yanuar*&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;Faculty of Pharmacy, Universitas Indonesia, 16424, Depok, INDONESIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nahid Mahmoud Hassan El-Ameen</style></author><author><style face="normal" font="default" size="100%">Manal Mohamed Elhassan Taha</style></author><author><style face="normal" font="default" size="100%">Siddig Ibrahim Abdelwahab</style></author><author><style face="normal" font="default" size="100%">Asaad Khalid</style></author><author><style face="normal" font="default" size="100%">Fatima Elfatih</style></author><author><style face="normal" font="default" size="100%">Mona Awad Kamel</style></author><author><style face="normal" font="default" size="100%">Bassem Yousif Sheikh</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Anti-diabetic Properties of Thymoquinone is unassociated with Glycogen Phosphorylase Inhibition</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Diabetes</style></keyword><keyword><style  face="normal" font="default" size="100%">Docking</style></keyword><keyword><style  face="normal" font="default" size="100%">Enzyme</style></keyword><keyword><style  face="normal" font="default" size="100%">Glycogen phosphorylase inhibition</style></keyword><keyword><style  face="normal" font="default" size="100%">Streptozotocin</style></keyword><keyword><style  face="normal" font="default" size="100%">Thymoquinone.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">01/2015</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">7</style></volume><pages><style face="normal" font="default" size="100%">406-410</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; &lt;em&gt;Nigella sativa&lt;/em&gt; L. (Black seed), is commonly used by traditional healers as a remedy for more than four thousand years. The antidiabetic property of &lt;em&gt;N. sativa&lt;/em&gt; seeds oil is attributable to the presence of Thymoquinone (TQ). On the other hand many studies have been designed to investigate the possible effects of the TQ in Streptozotocin (STZ) and nicotinamide (NA)-induced diabetes in rats. &lt;strong&gt;Aim of the study: &lt;/strong&gt;The aim of this study was to elucidate the mechanisms underlying the glucose lowering effects of thymoquinone. &lt;strong&gt;Methods:&lt;/strong&gt; &lt;em&gt;In vitro&lt;/em&gt; and &lt;em&gt;in silico&lt;/em&gt; using glycogen phosphorylase (GPa) enzyme assay and docking tools were used. &lt;strong&gt;Results:&lt;/strong&gt; Oral administration of TQ for 60 days, dose dependently improved the glycemic status in STZ-NA induced diabetic rats. GPa activity was measured in the direction of glycogen synthesis by the release of phosphate from glucose-1-phosphate. TQ at a concentration of 0.05 Mm inhibits GPa activity by only 14.9%. &lt;strong&gt;Conclusion:&lt;/strong&gt; These results show that TQ at 60 mg/kg b.w is associated with potential antihyperglycemic effects. Furthermore, anti-diabetic properties of TQ are unassociated with glycogen phosphorylase inhibition.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">406</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Nahid Mahmoud Hassan El-Ameen&lt;sup&gt;1*&lt;/sup&gt;, Manal Mohamed Elhassan Taha&lt;sup&gt;1*&lt;/sup&gt;, Siddig Ibrahim Abdelwahab&lt;sup&gt;1&lt;/sup&gt;, Asaad Khalid&lt;sup&gt;1&lt;/sup&gt;, Fatima Elfatih&lt;sup&gt;2&lt;/sup&gt;, Mona Awad Kamel&lt;sup&gt;1&lt;/sup&gt; and Bassem Yousif Sheikh&lt;sup&gt;3 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Biomedical Research Unit, Researcher at Medical Research Center, Jazan University, Jazan, Saudi Arabia.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Biochemistry Medicinal and Aromatic Plants Research Institute, National Centre for Research, P. O. Box 2420 Khartoum, Sudan.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Surgery, MABL Chair, College of Medicine, Taibah University, Saudi Arabia.&lt;/p&gt;</style></auth-address></record></records></xml>